Table: Zeria Pharm -2022/23 group results

Zeria Pharmaceutical

11/05/2023 08:00

May 11 (Reuters)- 
          Zeria Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           68.38           59.53          73.00        35.00    
               (+14.9 pct)     (+12.8 pct)    (+6.8 pct)    (+3.8 pct) 
  Operating        9.01            6.37           9.10         5.50    
               (+41.6 pct)     (+83.2 pct)    (+0.9 pct)    (-6.7 pct) 
  Recurring        7.58            5.94           9.00         5.50    
               (+27.7 pct)     (+85.0 pct)    (+18.7 pct)   (+6.1 pct) 
  Net
  Net              6.20            3.96           7.00         4.50    
               (+56.4 pct)     (+26.0 pct)    (+13.0 pct)  (+12.5 pct) 
  EPS          140.26 yen       87.76 yen     158.80 yen    102.09 yen 
  Ann Div       40.00 yen       35.00 yen      44.00 yen               
  -Q2 Div       18.00 yen       17.00 yen      22.00 yen               
  -Q4 Div       22.00 yen       18.00 yen      22.00 yen               
  
  NOTE - Zeria Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T